Anavex Life Sciences Corp (AVXL)

[falconer66a]

Anavex Has Submitted Actual Data to the EMA

Page 18, in the "Next Steps" portion of the slide:

Initiated regulatory submission of oral blarcamesine for Alzheimer's disease to European Medicines Agency (EMA)

As with the statement about the up-coming peer-reviewed journal article, nothing indecisive or conjectural. Anavex has initiated, actually has begun (past tense) to submit blarcamesine data to the EMA.

In regard to Missling's statement that there will be an upcoming peer-reviewed article in a journal, would he even have mentioned this if he knew that the data to be presented were negative and diminished the validity of blarcamesine's safety and efficacy?